These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
325 related articles for article (PubMed ID: 33918105)
21. Flecainide therapy in patients treated for supraventricular tachycardia with near normal left ventricular function. Hughes MM; Trohman RG; Simmons TW; Castle LW; Wilkoff BL; Morant VA; Maloney JD Am Heart J; 1992 Feb; 123(2):408-12. PubMed ID: 1736577 [TBL] [Abstract][Full Text] [Related]
22. [Life-threatening ventricular tachycardia during flecainide treatment for symptomatic atrial fibrillation in a patient with a structural cardiac disorder]. Rienstra M; Wiesfeld AC; van Veldhuisen DJ; van Gelder IC Ned Tijdschr Geneeskd; 2006 May; 150(18):1027-31. PubMed ID: 16715868 [TBL] [Abstract][Full Text] [Related]
23. Safety of flecainide versus propafenone for the long-term management of symptomatic paroxysmal supraventricular tachyarrhythmias. Report from the Flecainide and Propafenone Italian Study (FAPIS) Group. Chimienti M; Cullen MT; Casadei G Eur Heart J; 1995 Dec; 16(12):1943-51. PubMed ID: 8682031 [TBL] [Abstract][Full Text] [Related]
24. Intravenous Flecainide for Emergency Department Management of Acute Atrial Fibrillation. Markey GC; Salter N; Ryan J J Emerg Med; 2018 Mar; 54(3):320-327. PubMed ID: 29269083 [TBL] [Abstract][Full Text] [Related]
25. Arrhythmias in the intensive care patient. Trappe HJ; Brandts B; Weismueller P Curr Opin Crit Care; 2003 Oct; 9(5):345-55. PubMed ID: 14508146 [TBL] [Abstract][Full Text] [Related]
26. Advanced electrophysiologic mapping systems: an evidence-based analysis. Medical Advisory Secretariat Ont Health Technol Assess Ser; 2006; 6(8):1-101. PubMed ID: 23074499 [TBL] [Abstract][Full Text] [Related]
27. Intravenous Magnesium Sulfate Reduces the Need for Antiarrhythmics during Acute-Onset Atrial Fibrillation in Emergency and Critical Care. Gilardi E; Pomero F; Ravera E; Piccioni A; Santoro MC; Bonadia N; Carnicelli A; Di Maurizio L; Sabia L; Longhitano Y; Saviano A; Ojetti V; Savioli G; Zanza C; Franceschi F J Clin Med; 2022 Sep; 11(19):. PubMed ID: 36233391 [TBL] [Abstract][Full Text] [Related]
28. Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials. Naccarelli GV; Wolbrette DL; Khan M; Bhatta L; Hynes J; Samii S; Luck J Am J Cardiol; 2003 Mar; 91(6A):15D-26D. PubMed ID: 12670638 [TBL] [Abstract][Full Text] [Related]
29. Treatment with flecainide for symptomatic and refractory tachyarrhythmias in children. Ismail Z; Alwi M; Lim MK; Murtazam HA; Jamaluddin A Acta Paediatr Jpn; 1994 Feb; 36(1):44-8. PubMed ID: 8165907 [TBL] [Abstract][Full Text] [Related]
30. Three-month lower-dose flecainide after catheter ablation of atrial fibrillation. Hayashi M; Miyauchi Y; Iwasaki YK; Yodogawa K; Tsuboi I; Uetake S; Hayashi H; Takahashi K; Shimizu W Europace; 2014 Aug; 16(8):1160-7. PubMed ID: 24706088 [TBL] [Abstract][Full Text] [Related]
31. Pharmacological cardioversion of atrial fibrillation: current management and treatment options. Boriani G; Diemberger I; Biffi M; Martignani C; Branzi A Drugs; 2004; 64(24):2741-62. PubMed ID: 15563247 [TBL] [Abstract][Full Text] [Related]
33. Atrial flutter with flecainide-induced 1:1 conduction at a rate <200 b.p.m. at rest: a case report. Dardas S; Khan A Eur Heart J Case Rep; 2021 Oct; 5(10):ytab396. PubMed ID: 34703982 [TBL] [Abstract][Full Text] [Related]
34. Flecainide-Induced Atrial Flutter With 1:1 Conduction Complicated by Ventricular Fibrillation After Electrical Cardioversion. Colangelo T; Johnson D; Ho R Tex Heart Inst J; 2021 Jun; 48(2):. PubMed ID: 34086956 [TBL] [Abstract][Full Text] [Related]
35. Use of bepridil in combination with Ic antiarrhythmic agent in converting persistent atrial fibrillation to sinus rhythm. Imai S; Saito F; Takase H; Enomoto M; Aoyama H; Yamaji S; Yokoyama K; Yagi H; Kushiro T; Hirayama A Circ J; 2008 May; 72(5):709-15. PubMed ID: 18441448 [TBL] [Abstract][Full Text] [Related]
36. Clinical usefulness of flecainide acetate in the treatment of paroxysmal supraventricular arrhythmias. Camm AJ; Hellestrand KJ; Nathan AW; Bexton RS Drugs; 1985; 29 Suppl 4():7-13. PubMed ID: 4006783 [TBL] [Abstract][Full Text] [Related]
37. [Comparison of the efficacy and safety of dronedarone and flecainide as maintenance antiarrhythmic therapy for sinus rhythm in atrial fibrillation]. Sánchez Soriano RM; Chamorro Fernández CI; Ruiz Nodar JM; Chamorro Fernández AJ; Grau Jornet G; Nuñez Villota J Arch Cardiol Mex; 2018; 88(3):204-211. PubMed ID: 28864237 [TBL] [Abstract][Full Text] [Related]
38. Efficacy and safety of flecainide acetate for atrial tachycardia or fibrillation. Berns E; Rinkenberger RL; Jeang MK; Dougherty AH; Jenkins M; Naccarelli GV Am J Cardiol; 1987 Jun; 59(15):1337-41. PubMed ID: 3109229 [TBL] [Abstract][Full Text] [Related]
39. Flecainide intoxication in pediatric patients with supraventricular tachycardia. Vaquer G; Marfil L; Ortega J; Sabaté-Rotés A; Gran-Ipiña F; Roses-Noguer F Ann Pediatr Cardiol; 2020; 13(3):264-266. PubMed ID: 32863668 [TBL] [Abstract][Full Text] [Related]